Open AccessCYP2D6 gene resequencing in the Malagasy, a population at the crossroads between Asia and Africa: a pilot study
Author(s) -
E. Ricky Chan,
Rajeev K. Mehlotra,
Karim A Pirani,
Arsène Ratsimbasoa,
Scott M. Williams,
Andrea Gaedigk,
Peter A. Zimmerman
Publication year - 2022
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs-2021-0146
Subject(s) - biology , genetics , plasmodium vivax , haplotype , genotype , malaria , locus (genetics) , amplicon , taqman , concordance , evolutionary biology , primaquine , population , genetic variation , gene , plasmodium falciparum , polymerase chain reaction , chloroquine , demography , immunology , sociology
Background: Plasmodium vivax malaria is endemic in Madagascar, where populations have genetic inheritance from Southeast Asia and East Africa. Primaquine, a drug of choice for vivax malaria, is metabolized principally via CYP2D6. CYP2D6 variation was characterized by locus-specific gene sequencing and was compared with TaqMan™ genotype data. Materials & methods: Long-range PCR amplicons were generated from 96 Malagasy samples and subjected to next-generation sequencing. Results: The authors observed high concordance between TaqMan™-based CYP2D6 genotype calls and the base calls from sequencing. In addition, there are new variants and haplotypes present in the Malagasy. Conclusion: Sequencing unique admixed populations provides more detailed and accurate insights regarding CYP2D6 variability, which may help optimize primaquine treatment across human genetic diversity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom